CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants

NCT00788567 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: mycophenolate mofetil

Sponsor

Hoffmann-La Roche